OraSure Technologies Expands Board with New Member
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in diagnostic testing and sample management solutions, has made a notable advancement by electing Jack Kenny to its Board of Directors. This decision adds significant expertise to OraSure's leadership team, positioning the company to better adapt to the changing healthcare environment.
Jack Kenny's Background and Expertise
Jack Kenny comes to the board with extensive experience, having previously held the position of Chief Executive Officer at Meridian Bioscience. He was instrumental in revitalizing the company, which ultimately led to its acquisition. With more than 30 years in the diagnostics, molecular, and laboratory services sectors, Mr. Kenny's knowledge will be crucial as OraSure continues to innovate and grow its product offerings.
Mr. Kenny will serve as a Class I Director until the company’s Annual Meeting of Stockholders in 2025, enriching the Board with his varied operational experience. His previous roles include Senior Vice President and General Manager at Siemens Healthcare, as well as Vice President and General Manager for Becton Dickinson’s Diagnostic Systems, where he sharpened his strategic leadership abilities.
Insights from Mara Aspinall on the New Appointment
Mara Aspinall, Chair of the Board of Directors at OraSure, shared her excitement about Mr. Kenny’s addition to the team. "We recognize the immense value and industry knowledge that Jack will bring, and we are thrilled to further strengthen our Board with his involvement,” she remarked. Aspinall highlighted the company’s ongoing efforts to solidify its foundations and boost profitability, noting that Mr. Kenny's contributions will enhance these initiatives.
OraSure Technologies' Growth and Strategic Direction
Under the leadership of President and CEO Carrie Eglinton Manner, OraSure Technologies has been consistently growing and evolving. The inclusion of Mr. Kenny is anticipated to bolster the leadership team’s capabilities, enabling the company to meet the rising demands in the diagnostics market more effectively. OraSure Technologies is dedicated to enhancing healthcare accessibility, quality, and overall value through innovation and strategic planning.
About OraSure Technologies
OraSure Technologies is dedicated to transforming health by providing actionable insights and solutions that connect individuals with healthcare. The company specializes in developing and distributing rapid diagnostic tests and sample collection devices aimed at detecting critical health conditions. Alongside its subsidiary, DNA Genotek Inc., OraSure is a trusted name in the healthcare industry, delivering its products globally to various sectors, including clinical laboratories, hospitals, clinics, and public health organizations.
With a comprehensive product range that includes diagnostic tests and collection devices, OraSure is committed to meeting the evolving needs of healthcare professionals and patients alike. The company’s innovative solutions play a vital role in identifying and diagnosing medical conditions, reinforcing its dedication to improving public health on a global scale.
Contact Information for Investors and Media
For those seeking more information about OraSure Technologies, the company has established dedicated contacts for investor relations and media inquiries:
Investor Contact:
Jason Plagman
Vice President, Investor Relations
investorinfo@orasure.com
Media Contact:
Amy Koch
Director, Corporate Communications
media@orasure.com
Frequently Asked Questions
What role will Jack Kenny play in OraSure Technologies?
Jack Kenny will serve as a Class I Director on the Board, offering his extensive expertise in the diagnostics industry.
How does OraSure Technologies contribute to healthcare?
OraSure Technologies develops innovative diagnostic tests and sample management solutions that improve healthcare accessibility and quality.
What experience does Jack Kenny have in the healthcare sector?
Jack Kenny has over 30 years of experience in the diagnostics and lab services industries, including leadership roles at Meridian Bioscience and Siemens Healthcare.
Who leads OraSure Technologies?
OraSure Technologies is led by President and CEO Carrie Eglinton Manner, along with a diverse and experienced Board of Directors.
What is the significance of the new appointment?
Jack Kenny's appointment to the Board aims to enhance strategic decision-making and drive growth for OraSure Technologies as it navigates a competitive market.